Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1981-07-02
1983-02-01
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
424246, 42424851, 42424853, 42424854, 424250, 424267, 424274, 424275, 544 581, 544 582, 544 587, 544146, 544168, 544379, 544400, 546205, 546213, 546233, 546234, 548527, 548568, 260239BF, 2603303, 2603306, 542426, A61K 31535, A61K 3155, C07D29514
Patent
active
043715303
ABSTRACT:
Compounds are described of the formula ##STR1## in which R.sup.1 is unsubstituted or substituted phenylalkyl, thienylalkyl or naphthylalkyl, or cinnamyl;
REFERENCES:
patent: 4182903 (1980-01-01), Favara
patent: 4189606 (1980-02-01), Favara
patent: 4265891 (1981-05-01), Collington et al.
Le Breton et al., Proc. Natl. Acad. Sci. USA, vol. 76, (1979), 4097-4100.
Orth et al., Topics in Current Chemistry, 72, 51-97, (1977).
Collington Eric W.
Hallet Peter
Hayes Norman F.
Wallis Christopher J.
Glaxo Group Limited
Ramsuer Robert W.
LandOfFree
Aminocyclopentanone amides and pharmaceutical formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminocyclopentanone amides and pharmaceutical formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminocyclopentanone amides and pharmaceutical formulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2407394